Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Management of Chronic Myeloid Leukemia

EP. 1: An Overview of Chronic Myeloid Leukemia

August 15th 2018

EP. 2: RT PCR Testing in CML: Finding BCR-ABL TKI Candidates

August 15th 2018

EP. 3: CML: Frontline BCR-ABL TKI Therapy

August 15th 2018

EP. 4: CML: Factors in Selecting a BCR-ABL TKI

August 15th 2018

EP. 5: When to Switch Therapy in Chronic Myeloid Leukemia

August 15th 2018

EP. 6: TIDEL-II: Switching From Imatinib to Nilotinib in CML

August 15th 2018

EP. 7: CML: Considering Second-Generation TKIs

August 15th 2018

EP. 8: Optimizing the Use of BCR-ABL TKIs in CML

August 15th 2018

EP. 9: Chronic Myeloid Leukemia: Understanding Loss of Response

August 15th 2018

EP. 10: CML: Improving Treatment for Patients Who Don't Respond

August 15th 2018

EP. 11: Achieving Treatment-Free Remissions in CML

August 15th 2018

EP. 12: Chronic Myeloid Leukemia: Selecting Patients for TFR

August 15th 2018

EP. 13: TFR With Nilotinib in CML: ENESTfreedom and ENESTop

August 15th 2018

EP. 14: Unmet Needs and Future Directions in CML

August 15th 2018
Advertisement
Advertisement

Trending on OncLive

1

Experts Unpack Crucial Hematologic Oncology Data From ASCO 2026

2

International Intel: A Glance at the Top Global Breast Cancer News From April-June 2026

3

MYTHOS Misses Prespecified ORR End Point With T-DXd in HER2-Low Salivary Gland Carcinoma

4

Subcutaneous Pembrolizumab Faces Scrutiny Over Convenience and Cost for Patients With Cancer

5

Orelabrutinib Generates Significant Survival Benefits in Treatment-Naive CLL

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us